anonymous
Guest
anonymous
Guest
Please stop telling offices you are getting Xiidra and their current reps are going to get cut. 99% of these offices are telling us and we are having a nice laugh at your expense. If you think Novartis will spend all that money on xiidra and then just hand it over to an untrained workforce you need your head examined. Most of the offices dont even know who their Alcon/Novartis rep is and still refer to you as Alcon.